-
Z-VEID-FMK: From Caspase-6 to Antiviral Insight
2026-08-14
A translational framework for using Z-VEID-FMK to test caspase-6 dependence in apoptosis and emerging antiviral mechanisms, with a focus on the DDX23–SVA interaction and the controls needed to distinguish causal protease activity from downstream cell death.
-
Nonivamide (Capsaicin Analog) Assay Guide
2026-08-14
This scenario-based guide explains how Nonivamide (Capsaicin Analog), SKU A3278, can support reproducible cell viability, proliferation, and apoptosis workflows. It connects TRPV1 biology with practical solvent handling, orthogonal endpoint selection, and evidence-based vendor evaluation.
-
Hematoxylin and Eosin Staining Kit Guide
2026-08-13
The H&E staining kit provides ready-to-use hematoxylin and eosin solutions for visualizing nuclei, cytoplasm, extracellular matrix, and overall tissue architecture in research samples. It is intended for histological and cytological research, including paraffin-embedded and frozen sections, and must not be used for clinical diagnosis or medical decision-making.
-
PRRSV N Protein, Caspase-6, and IFN Evasion
2026-08-13
The reference study identifies a previously unrecognized PRRSV strategy in which host caspase-6 cleaves the viral N protein at the conserved D94 site, suppressing IRF3 signaling and type I interferon production. Reverse-genetics evidence shows that preventing this cleavage attenuates viral replication and pathogenicity, providing a mechanistic basis for antiviral target discovery and live attenuated vaccine design.
-
Z-VEID-FMK for Caspase-6 Pathway Mapping
2026-08-12
Z-VEID-FMK is a cell-permeable caspase-6 inhibitor for separating protease activity from upstream inflammatory and apoptotic signals. This guide translates recent Homer1a–caspase-6 findings into practical assay design, controls, and interpretation strategies.
-
Z-VEID-FMK for Caspase-6 Pathway Studies
2026-08-12
Z-VEID-FMK is a cell-permeable, irreversible caspase-6 inhibitor for separating caspase-6-dependent substrate cleavage from broader apoptotic events. This workflow translates that selectivity into practical apoptosis, neuronal, immune, cancer, and host–pathogen experiments while emphasizing solvent control, timing, and orthogonal validation.
-
Cy3 Rabbit Anti-Goat IgG (H+L) Antibody Guide
2026-08-11
The Cy3 Rabbit Anti-Goat IgG (H+L) Antibody detects goat IgG primary antibodies in fluorescence-based ICC/IF, IHC, flow cytometry, and ELISA workflows. It should be reserved for validated immunodetection assays involving goat IgG and is not a general secondary reagent for non-goat primaries or unrelated applications.
-
WP1066 as a JAK2/STAT3 Pathway Probe
2026-08-11
WP1066, a cell-permeable JAK2/STAT3 inhibitor, can do more than suppress cancer signaling. This article presents an assay-centered framework for connecting pathway inhibition, oncology phenotypes, and carefully bounded macrophage-regeneration studies.
-
DiR: Interpreting EV Trafficking Beyond Fluorescence
2026-08-10
DiR and DiIC 18 (7) provide deep-red membrane labeling for long-term cell and tissue tracking. This article shows how to use the probe critically in extracellular vesicle studies, distinguishing fluorescence distribution from genuine therapeutic delivery.
-
Omeprazole (A2845): Research Workflow Guide
2026-08-09
Omeprazole (A2845) provides a defined H+,K+-ATPase inhibitor for gastric acid secretion research, antiulcer activity studies, and related experimental models. This guide addresses solvent selection, assay setup, storage, and QC while clarifying that the material is for scientific research only and is unsuitable for diagnostic, medical, or clinical use.
-
Annexin V-FITC/PI Apoptosis Assay Kit Guide
2026-08-08
The Annexin V-FITC/PI Apoptosis Assay Kit (SKU K2003) provides a two-parameter fluorescence assay for separating viable, early apoptotic, and membrane-compromised cell populations. It is suitable for research flow cytometry or fluorescence microscopy, but it should not be used as a standalone diagnostic test or as definitive proof of a specific cell-death mechanism.
-
Homer1a–Caspase-6 Signaling in Inflammatory Pain
2026-08-07
A 2025 preclinical study identifies the Homer1a/caspase-6/TNF-α axis as a regulator of inflammatory pain in the rat spinal dorsal horn. Pharmacological inhibition and lentiviral Homer1a overexpression both reduced microglial activation, TNF-α signaling, and thermal hypersensitivity, providing a mechanistic framework for studying nonapoptotic caspase-6 activity.
-
Notch Inhibition Boosts Immune Checkpoint Therapy in TNBC
2026-08-07
The referenced study demonstrates that targeting the Notch signaling pathway enhances the response of triple-negative breast cancer (TNBC) to immune checkpoint blockade (ICB). By reducing tumor-associated macrophages and promoting cytotoxic T cell infiltration, Notch inhibition transforms the tumor immune microenvironment, offering a promising therapeutic avenue for aggressive breast cancers.
-
RNA Clean and Concentrator Kit: Streamlining RNA Purificatio
2026-08-06
The APExBIO RNA Clean and Concentrator Kit delivers rapid, high-fidelity RNA purification from enzymatic reactions, including in vitro transcription, with streamlined spin column technology. Empower robust gene expression studies in mitophagy and NAFLD models by integrating this kit into your workflow for reproducible, contaminant-free RNA.
-
Rethinking Clozapine: Mechanistic Insights for Translational
2026-08-06
This thought-leadership article explores how Clozapine's unique multi-receptor activity and ERK1/2 signaling modulation provide a powerful translational platform for schizophrenia research. Bridging molecular pharmacology with recent advances in neuromodulation, we guide researchers through strategic experiment design and future directions for multidimensional intervention—highlighting both APExBIO's Clozapine and the latest breakthroughs targeting GABAA receptor circuits.